Skip to main content
. Author manuscript; available in PMC: 2015 Sep 10.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2014 Jan 14;17(1):91–96. doi: 10.1038/pcan.2013.59

Table 3.

Percent risk of positive scan by PSA and PSADT groups stratified by ADT status

PSADT (months) Before ADT
After ADT
PSA (ng ml−1) PSA (ng ml−1)
0–4.9 5–9.9 10–19.9 ≥20 0–4.9 5–9.9 10–19.9 ≥20
≥9 1 (1–2) 1 (0–6) 5 (2–15) 3 (1–10) 10 (8–13) 17 (8–32) 30 (21–40) 39 (32–47)
3–8.9 11 (9–14) 10 (3–27) 31 (16–53) 24 (14–37) 19 (16–22) 30 (17–48) 47 (36–58) 57 (52–62)
< 3 24 (11–43) 22 (5–60) 53 (26–79) 44 (22–68) 26 (20–33) 40 (22–61) 57 (45–69) 67 (61–73)

Abbreviations: ADT, androgen deprivation therapy; PSADT, PSA doubling time.